Rachel E. Barenie, Pharm.D., J.D., M.P.H.
Dr. Barenie earned her Pharm.D. from Butler University in Indianapolis, Indiana, and holds active pharmacist licensures in Indiana and Tennessee. She also earned her J.D. and M.P.H from the University of Memphis and is admitted to the Tennessee Bar.
Prior to joining PORTAL, she led the University of Memphis Law Review’s 2018 Symposium titled The American Addiction: Pathways to Address the Opioid Crisis, and her Note, CARA and the FDA: The Call to Convene and the Charge to Clarify, was selected for publication in Book 4, the companion volume to the symposium.
She is interested in data-driven health policy; drug use, misuse, and addiction; and issues at the intersection of health, public health, and the law. Dr. Barenie also serves as a clinical consultant to Alosa Health, a non-profit organization that promotes evidence-based prescribing and academic detailing, and on the Advisory Committee for the American Pharmacists Association Institute on Substance Use Disorders.
Prior to joining PORTAL, she led the University of Memphis Law Review’s 2018 Symposium titled The American Addiction: Pathways to Address the Opioid Crisis, and her Note, CARA and the FDA: The Call to Convene and the Charge to Clarify, was selected for publication in Book 4, the companion volume to the symposium.
She is interested in data-driven health policy; drug use, misuse, and addiction; and issues at the intersection of health, public health, and the law. Dr. Barenie also serves as a clinical consultant to Alosa Health, a non-profit organization that promotes evidence-based prescribing and academic detailing, and on the Advisory Committee for the American Pharmacists Association Institute on Substance Use Disorders.
Back to PORTAL Research Team
